Ceftriaxone - Injection products
Recognized Interpretive Criteria
Exceptions to the recognized standard of CLSI M100
|
Minimum Inhibitory Concentrations |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Enterobacteralesa |
M100 standard is recognized |
|||||
Haemophilus influenzae and |
M100 standard is recognized |
|||||
Neisseria gonorrhoeae |
M100 standard is recognized |
|||||
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus pneumoniae |
M100 standard is recognized |
- |
- |
- |
||
Streptococcus spp β- Hemolytic Group |
M100 standard is recognized |
|||||
Streptococcus spp Viridans Group |
M100 standard is recognized |
|||||
Neisseria meningitidis |
M100 standard is recognized |
|||||
Anaerobes |
≤1 |
2 |
≥4 |
- |
- |
- |
aIncluding Salmonella spp. and Shigella spp.
S = Susceptible; I = Intermediate; R = Resistant
Susceptibility interpretive criteria recognized for Enterobacterales are based on a dose of 1 gram IV q 24h. For isolates with intermediate susceptibility, use a dose of 2 grams IV q 24h in patients with normal renal function.
For Haemophilus influenzae and parainfluenzae, susceptibility interpretive criteria recognized in CLSI M100 are based on a dose of 2 grams IV every 24 hours in patients with normal renal function.
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp
Other Non-Enterobacterales